Pharmacological Management of Acute and Persistent Aggression in Forensic Psychiatry Settings

被引:28
作者
Citrome, Leslie [1 ]
Volavka, Jan [2 ]
机构
[1] New York Med Coll, Dept Psychiat & Behav Sci, Valhalla, NY 10595 USA
[2] NYU, Sch Med, Dept Psychiat, New York, NY USA
关键词
PLACEBO-CONTROLLED TRIAL; BORDERLINE PERSONALITY-DISORDER; INTERMITTENT EXPLOSIVE DISORDER; POST HOC ANALYSIS; DOUBLE-BLIND; ACUTE AGITATION; INTRAMUSCULAR HALOPERIDOL; SCHIZOAFFECTIVE DISORDER; SCHIZOPHRENIC-PATIENTS; PSYCHOTIC AGITATION;
D O I
10.2165/11596930-000000000-00000
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aggressive behaviour is common in forensic psychiatric settings. The aetiology of aggressive behaviour is multifactorial and can be driven by psychosis, impulsivity, psychopathy, intoxication, cognitive impairment, or a combination of all of these. Recognition of the different factors behind the aggression can inform medication selection and the relative need for specific environmental and behavioural interventions in a forensic psychiatric setting. Acute agitation needs to be managed quickly and effectively before further escalation of the behavioural dyscontrol occurs. Benzodiazepines and/or antipsychotic medications are often used and can be given intramuscularly to achieve a rapid onset of action. Available are intramuscular preparations of second-generation antipsychotics that have similar efficacy to lorazepam and haloperidol in reducing agitation, but are well tolerated and not associated with the extrapyramidal adverse effects, including akathisia, that can plague the older first-generation antipsychotics. The longer-term management of persistent aggressive behaviour can be quite complex. A major obstacle is that the causality of aggressive events can differ from patient to patient, and also from event to event in the same patient. For patients with schizophrenia and persistent aggressive behaviour, clozapine is recommended both for its superior antipsychotic effect and its specific anti-hostility effect. Mood stabilizers such as valproate may be helpful in instances of poor impulsivity and personality disorders. Other agents that have been successfully used include beta-adrenoceptor antagonists (beta-blockers) and antidepressants.
引用
收藏
页码:1009 / 1021
页数:13
相关论文
共 84 条
  • [1] Chlorpromazine for psychosis induced aggression or agitation
    Ahmed, Uzair
    Jones, Hannah
    Adams, Clive E.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (04):
  • [2] Insight into illness and adherence to psychotropic medications are separately associated with violence severity in a forensic sample
    Alia-Klein, Nelly
    O'Rourke, Thomas M.
    Goldstein, Rita Z.
    Malaspina, Dolores
    [J]. AGGRESSIVE BEHAVIOR, 2007, 33 (01) : 86 - 96
  • [3] Allen MH, J CLIN PSYCHIAT
  • [4] Effect of Nicotine Replacement Therapy on Agitation in Smokers With Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Study
    Allen, Michael H.
    Debanne, Martin
    Lazignac, Coralie
    Adam, Eric
    Dickinson, L. Miriam
    Damsa, Cristian
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (04) : 395 - 399
  • [5] ALPERT M, 1990, PSYCHOPHARMACOL BULL, V26, P367
  • [6] Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol
    Andrezina, Raisa
    Josiassen, Richard C.
    Marcus, Ronald N.
    Oren, Dan A.
    Manos, George
    Stock, Elyse
    Carson, William H.
    Iwamoto, Taro
    [J]. PSYCHOPHARMACOLOGY, 2006, 188 (03) : 281 - 292
  • [7] [Anonymous], 162 ANN M AM PSYCH A
  • [8] Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence
    Arango, C
    Bombín, I
    González-Salvador, T
    García-Cabeza, I
    Bobes, J
    [J]. EUROPEAN PSYCHIATRY, 2006, 21 (01) : 34 - 40
  • [9] The effect of quetiapine on aggression and hostility in patients with schizophrenia
    Arango, C
    Bernardo, M
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (04) : 237 - 241
  • [10] Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation
    Baker, RW
    Kinon, BJ
    Maguire, GA
    Liu, H
    Hill, AL
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (04) : 342 - 348